$3.07 Billion in Sales Expected for Unum Group (NYSE:UNM) This Quarter
Brokerages forecast that Unum Group (NYSE:UNM) will announce sales of $3.07 billion for the current quarter, Zacks Investment Research reports. Nine analysts have made estimates for Unum Group’s earnings. The highest sales estimate is $3.09 billion and the lowest is $3.04 billion. Unum Group posted sales of $2.99 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 2.7%. The business is scheduled to announce its next quarterly earnings results on Tuesday, May 5th.
On average, analysts expect that Unum Group will report full year sales of $12.31 billion for the current year, with estimates ranging from $12.17 billion to $12.39 billion. For the next year, analysts forecast that the company will post sales of $12.62 billion, with estimates ranging from $12.47 billion to $12.78 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research firms that cover Unum Group.
Unum Group (NYSE:UNM) last announced its quarterly earnings data on Tuesday, February 4th. The financial services provider reported $1.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.38 by $0.03. The firm had revenue of $3.03 billion for the quarter, compared to the consensus estimate of $3.02 billion. Unum Group had a net margin of 9.17% and a return on equity of 11.97%. The business’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same period in the prior year, the company posted $1.30 earnings per share.
Shares of NYSE UNM opened at $15.97 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.16 and a quick ratio of 0.16. Unum Group has a 1 year low of $9.58 and a 1 year high of $38.00. The company has a 50 day simple moving average of $22.21 and a 200 day simple moving average of $27.29. The firm has a market cap of $2.97 billion, a PE ratio of 3.05, a price-to-earnings-growth ratio of 0.28 and a beta of 1.56.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Penserra Capital Management LLC boosted its position in Unum Group by 8.6% in the fourth quarter. Penserra Capital Management LLC now owns 4,928 shares of the financial services provider’s stock worth $133,000 after purchasing an additional 392 shares during the last quarter. Signaturefd LLC boosted its holdings in shares of Unum Group by 11.7% in the 4th quarter. Signaturefd LLC now owns 3,920 shares of the financial services provider’s stock worth $114,000 after purchasing an additional 412 shares during the period. Cutter & CO Brokerage Inc. increased its position in shares of Unum Group by 5.1% during the 4th quarter. Cutter & CO Brokerage Inc. now owns 10,773 shares of the financial services provider’s stock valued at $314,000 after purchasing an additional 520 shares during the last quarter. Franklin Resources Inc. increased its position in shares of Unum Group by 1.7% during the 4th quarter. Franklin Resources Inc. now owns 38,438 shares of the financial services provider’s stock valued at $1,121,000 after purchasing an additional 658 shares during the last quarter. Finally, Brooks Moore & Associates Inc. increased its position in shares of Unum Group by 3.3% during the 4th quarter. Brooks Moore & Associates Inc. now owns 23,291 shares of the financial services provider’s stock valued at $679,000 after purchasing an additional 734 shares during the last quarter. 93.29% of the stock is currently owned by hedge funds and other institutional investors.
Unum Group Company Profile
Unum Group, together with its subsidiaries, provides financial protection benefit solutions in the United States, the United Kingdom, and internationally. It operates through Unum US, Unum UK, Colonial Life, and Closed Block segments. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Unum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unum Group and related companies with MarketBeat.com's FREE daily email newsletter.